Literature DB >> 8468348

Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein (APP): cleavage of APP occurs in a late compartment of the default secretion pathway.

B De Strooper1, L Umans, F Van Leuven, H Van Den Berghe.   

Abstract

Amyloid precursor protein (APP) secretase plays a pivotal role in the processing of APP since its activity precludes the formation of amyloid peptide in Alzheimer's Disease. The identity and the subcellular localization of this enzyme are at this moment unknown. It is also unclear how APP escapes the activity of this enzyme when amyloid is formed. We have previously shown that APP-secretase activity is not inhibited by exogenously added proteinase inhibitors of different specificity (De Strooper, B., F. Van Leuven, and H. Van Den Berghe. 1992. FEBS (Fed. Eur. Biochem. Soc.) Lett. 308:50-53). We show here that the primary amine methylamine inhibits the secretion of APP into the medium. Furthermore, we show that a truncated form of APP, devoid of the cytoplasmic domain, is more efficiently cleaved and secreted than wild-type APP, which together with the methylamine block, shows that APP-secretase is located in a late compartment of the default constitutional secretion pathway. The sorting signals in the cytoplasmic domain of APP are therefore important in the deviation of APP from the secretase pathway. Finally we show that mutation of Arg609 to Asp in combination with Lys612 to Glu makes APP a less efficiently cleaved substrate for APP-secretase. The results are discussed in the context of recent findings on the targeting of APP and a parallel is drawn with some lysosomal glycoproteins that follow similar pathways.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8468348      PMCID: PMC2200101          DOI: 10.1083/jcb.121.2.295

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  51 in total

Review 1.  Amyloid beta protein precursor and the pathogenesis of Alzheimer's disease.

Authors:  D J Selkoe
Journal:  Cell       Date:  1989-08-25       Impact factor: 41.582

2.  Primary amines inhibit recycling of alpha 2M receptors in fibroblasts.

Authors:  F Van Leuven; J J Cassiman; H Van Den Berghe
Journal:  Cell       Date:  1980-05       Impact factor: 41.582

3.  Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity.

Authors:  N Kitaguchi; Y Takahashi; Y Tokushima; S Shiojiri; H Ito
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

4.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

5.  Studies on the effect of lysosomotropic agents on the release of Gal beta 1-4GlcNAc alpha-2,6-sialytransferase from rat liver slices during the acute-phase response.

Authors:  G Lammers; J C Jamieson
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

6.  A novel mRNA of the A4 amyloid precursor gene coding for a possibly secreted protein.

Authors:  F de Sauvage; J N Octave
Journal:  Science       Date:  1989-08-11       Impact factor: 47.728

7.  High efficiency polyoma DNA transfection of chloroquine treated cells.

Authors:  H Luthman; G Magnusson
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

8.  Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Authors:  C L Masters; G Simms; N A Weinman; G Multhaup; B L McDonald; K Beyreuther
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

9.  Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch).

Authors:  C Van Broeckhoven; J Haan; E Bakker; J A Hardy; W Van Hul; A Wehnert; M Vegter-Van der Vlis; R A Roos
Journal:  Science       Date:  1990-06-01       Impact factor: 47.728

10.  Lysosomal acid phosphatase is transported to lysosomes via the cell surface.

Authors:  M Braun; A Waheed; K von Figura
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

View more
  22 in total

1.  Soluble form of complement C3b/C4b receptor (CR1) results from a proteolytic cleavage in the C-terminal region of CR1 transmembrane domain.

Authors:  I Hamer; J P Paccaud; D Belin; C Maeder; J L Carpentier
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

2.  Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease.

Authors:  S Lammich; E Kojro; R Postina; S Gilbert; R Pfeiffer; M Jasionowski; C Haass; F Fahrenholz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein.

Authors:  J P Borg; J Ooi; E Levy; B Margolis
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

4.  Inhibition of beta A4 production by specific modulation of beta-secretase activity.

Authors:  B Urmoneit; C Reinsch; J Turner; C Czech; K Beyreuther; T Dyrks
Journal:  J Mol Neurosci       Date:  1995       Impact factor: 3.444

Review 5.  The role of beta-amyloid peptide in Alzheimer's disease.

Authors:  A LeBlanc
Journal:  Metab Brain Dis       Date:  1994-03       Impact factor: 3.584

6.  Association of a novel human FE65-like protein with the cytoplasmic domain of the beta-amyloid precursor protein.

Authors:  S Y Guénette; J Chen; P D Jondro; R E Tanzi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Retention in endoplasmic reticulum 1 (RER1) modulates amyloid-β (Aβ) production by altering trafficking of γ-secretase and amyloid precursor protein (APP).

Authors:  Hyo-Jin Park; Daniil Shabashvili; Michael D Nekorchuk; Eva Shyqyriu; Joo In Jung; Thomas B Ladd; Brenda D Moore; Kevin M Felsenstein; Todd E Golde; Seong-Hun Kim
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

8.  5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10.

Authors:  Maud Cochet; Romain Donneger; Elisabeth Cassier; Florence Gaven; Stefan F Lichtenthaler; Philippe Marin; Joël Bockaert; Aline Dumuis; Sylvie Claeysen
Journal:  ACS Chem Neurosci       Date:  2012-10-13       Impact factor: 4.418

9.  Inhibition of death-associated protein kinase 1 attenuates the phosphorylation and amyloidogenic processing of amyloid precursor protein.

Authors:  Byeong Mo Kim; Mi-Hyeon You; Chun-Hau Chen; Jaehong Suh; Rudolph E Tanzi; Tae Ho Lee
Journal:  Hum Mol Genet       Date:  2016-04-19       Impact factor: 6.150

10.  Characterization of endogenous APP processing in a cell-free system.

Authors:  A M Brown; A Potempska; D Tummolo; M A Spruyt; J S Jacobsen; J Sonnenberg-Reines
Journal:  Age (Omaha)       Date:  1998-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.